Endo Teeters On The Edge, Revlon Equity Committee Sought
Endo Pharmaceuticals said it is close to filing for bankruptcy over its opioid liability, Revlon shareholders want representation in its Chapter 11 case, and a North Carolina judge said sanctions worked...To view the full article, register now.
Already a subscriber? Click here to view full article